DV
Dividend Vision

KALV — KalVista Pharmaceuticals, Inc.

No longer trading. This fund has been liquidated; the figures below are frozen at its final trading day.

KalVista Pharmaceuticals, Inc. (KALV)

KALV is a healthcare equity stock that operates in the pharmaceutical sector. As an individual stock rather than a diversified fund, it does not currently pay distributions and lacks the typical ETF characteristics such as a stated expense ratio or regular distribution schedule. This security appeals primarily to growth-oriented investors seeking exposure to the biotechnology and pharmaceutical industry rather than those focused on current income generation. Trading ceased after 06/12/2026; the shares last closed at $27.00. No later quote reflects a live market.

KALV key facts

Asset type
Stock
Asset class
Equity
Inception date
04/09/2015
Last close
$27.00
Market cap
$1,437,504,000
Average volume
3625508.0
Payment date
11/22/2016
Beta
-0.109
Payout ratio
0.0
Forward P/E
17.4757
EPS
$-3.94